Ethosuximide
NDC Package 61748-024-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ethosuximide is a medication used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). Marketed by Versapharm Incorporated, this product is identified by NDC 61748-024 and is authorized under FDA application ANDA040506.

Identification & Billing

NDC Package Code
61748-024-16
Package Description
473 mL in 1 BOTTLE, PLASTIC
Product Code
61748-024
11-Digit Billing Format
61748002416
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML

Clinical Specifications

Proprietary Name
Ethosuximide
Dosage Form
-
Usage Information
This medication is used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

Regulatory & Marketing

Labeler Name
Versapharm Incorporated
FDA Application #
ANDA040506
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-01-2004
End Marketing Date
12-31-2020
Listing Expiration
12-31-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61748-024-16 identifies a specific commercial package of 473 ml in 1 bottle, plastic of Ethosuximide, labeled by Versapharm Incorporated. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Versapharm Incorporated on January 01, 2004. The current certification is valid through December 31, 2020.

What are the primary indications for this medication?

This medication is used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

How is this Versapharm Incorporated product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61748002416. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61748-024-16
11-Digit CMS (5-4-2)
61748-0024-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.